Approval · Notice of Compliance 16494 · 2015
LUVOX: Notice of Compliance 16494
Issued January 7, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16494
- Date
- January 7, 2015
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug idneitification numbers
- Therapeutic class
- Antidepressant, antiobsessional agent
Products in this notice
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB